iiinova — where your digital self keeps evolving

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 12/08/2026

Join in on our next CPC - focusing on potential ID challenges of transplant tourism! Wed Sept 2 @ 7am EST, 2pm Riyadh A great interactive case discussion with expert education. @bradgardiner.bsky.social @kottonnelson.bsky.social @tidsection.bsky.social tts.org/component/co...

031

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 30/03/2026

On behalf of the TID section of TTS, ESGICH and the @thetxidjournal.bsky.social we invite you to: ESGICH – CPC Webinar: Thursday, April 9, 2026, at 14:00 CET  A Neglected Tropical Disease Beyond Endemic Borders: A Case-Based Discussion Registration link: us06web.zoom.us/webinar/regi...

040

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 15/11/2025

I had the HUGE honor of being the 40th Forbes Fellow - when I was the previous awardees, I was truly humbled. The ID community is incredible in Melbourne. @monashuniversity.bsky.social @unimelb.bsky.social @thedohertyinst.bsky.social @trubianojason.bsky.social @bradgardiner.bsky.social

1122

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 17/09/2025

The ISRV AVG meeting kicked of by Fred Hayden giving the 2nd Roberts/Tisdale lecture on the clinical implications of antiviral resistance.

260

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 14/05/2025

Michael Woodward presented on utility of FMT in ICHs - can reduce risk of recurrent C diff and MDRO infections - cost, availability and lack of guidance are limiting application @fredhutch 5th Symposium on ID in ICHs. www.science.org/doi/10.1126/...

1131

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 14/05/2025

Likewise, screening for FQ resistance may inform what breakthrough infections will occur and optimize early management.

020

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 14/05/2025

Mike Satlin gave an incredible review of MDR-GBR. These challenging bacteria cause freq infections and screening for can inform management of F&N @fredhutch.bsky.social 5th Symposium on ID in ICHs.

2111

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 14/05/2025

Jay Fishman provided the keynote on Xenotransplantation- major progress but many unknowns- thankfully formal clinical trials will help inform optimal approach @fredhutch.bsky.social 5th Symposium on ID in ICHs.

061

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 13/05/2025

Erika Kampouri provided a masterful review of infections after CAR-T and the impact of CMV and HHV6 in these patients - HHV6 CNS disease rare, CMV needs more data to confirm optimal management. @fredhutch.bsky.social 5th Symposium on ID in ICHs onlinelibrary.wiley.com/doi/10.1111/...

1132

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 13/05/2025

The future may be using the tool to look at pathogen and host response in the same assay - multiple examples shown that the combined approach provided answers that wouldn’t have been identified.

140

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 13/05/2025

Charles Chiu @UCSF gave an amazing lecture on mNGS in immunocompromised- while helpful, limitations exist and must be recognized to interpret the results.

162

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 12/05/2025

Hans Hirsch provided a master class in BKV as the keynote for the 5th @fredhutch.bsky.social Symposium on Infections in ICH. Studies have advanced our understanding of pathogens and management - but many questions remain.

163

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 12/05/2025

Michael Boeckh highlights the grow of the the @fredhutch Symposium on Infections - matching interest the field of #TxID It’s easy to see why with an expansion of tools to study and apply to improve outcomes in our patients!

1112

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 12/04/2025

A true master class on Chagas in transplantation - emerging data supports the safety of using Chagas positive donors with careful monitoring and treatment. Marcelo Radisic #ESCMIDGlobal

051

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 12/04/2025

Great review of TB in endemic regions including approaches to use universal prophylaxis to reduce the incidence of post-transplant infection. @RubinaNaqvi1

010

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 12/04/2025

Great talk about HHV8 and the role of donor screening by Alesandra Mularone including follow-up management. linkinghub.elsevier.com/retrieve/pii...

110

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 02/12/2024

Join Hans Hirsch & I for our next ESGICH-ESGREV Webinar on the Management of Respiratory Viral Infections in the Immunocompromised. 3 amazing speakers and time for questions and discussion about challenging cases. Tuesday December 10 at 5pm CET Register today: buff.ly/4idBQhV

041

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 23/11/2024

Key reminder - COVID-19 is still around. I had super mild symptoms and tested because we had plans for a dinner party later tonight! As we all plan to travel and visit family - test if you have any respiratory symptoms and isolate - many you’ll be visiting may be at higher risk of severe dz!

1111

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 18/11/2024

Want to learn about the treatment of RVI in immunocompromised patients? Join us for the next @ESCMID.bsky.social ESGICH/ESGREV webinar on the treatment of RVI. Chairs: Hans Hirsch and @michaelisonmd.bsky.social Talks by: Pauline Vetter, Jose Luise Pinana, Fareed Khawaja

23413